Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Maravai LifeSciences Holdings, Inc. (MAR.F)

1.8100
+0.0100
+(0.56%)
As of 8:05:02 AM GMT+2. Market Open.

Research Analysis

Revenue vs. Earnings

Revenue 56.56M
Earnings -14.93M

Q1'24

Q2'24

Q3'24

Q4'24

0
20M
40M
60M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 13121414
Avg. Estimate 44.01M48.41M192.75M211.15M
Low Estimate 43M44.6M185M170.78M
High Estimate 46.8M57.6M212.1M230.43M
Year Ago Sales 64.18M73.4M259.19M192.75M
Sales Growth (year/est) -31.43%-34.05%-25.63%9.55%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
MAR.F --------
S&P 500 6.94%4.52%8.32%14.18%

Upgrades & Downgrades

Maintains Morgan Stanley: Equal-Weight to Equal-Weight 3/25/2025
Maintains UBS: Neutral to Neutral 3/21/2025
Maintains B of A Securities: Buy to Buy 3/3/2025
Downgrade Baird: Outperform to Neutral 2/26/2025
Downgrade Goldman Sachs: Neutral to Sell 12/5/2024
Initiated Wolfe Research: Peer Perform 11/14/2024

Related Tickers